For the past couple of years, the stock market has been defined by Tech and artificial intelligence. A handful of mega-cap technology companies, dubbed the "Magnificent Seven," drove the lion's share of returns earlier on, then AI stocks flourished ..creating extraordinary wealth for investors but also generating significant concentration risk. However, the winds of change are blowing. A powerful sector rotation has been underway, and it signals the return of a more traditional and rational investment principle: fundamental valuation and this is normal and healthy.

Investors are increasingly looking beyond the narrow AI trade and reallocating capital into sectors like financials, healthcare, industrials, and energy. This is not a signal that the tech rally is over forever; AI remains a powerful, long-term transformative force. Rather, this rotation is a healthy market correction, driven by stretched valuations and the simple realization that other sectors offer compelling value and solid earnings growth. After a period where narrative often overshadowed fundamentals, rationality is making a welcome comeback.

The AI Story: A Momentary Pause, Not a Finale

The AI trade has been a phenomenal success story, driven by spectacular earnings growth, strong adoption, and massive capital expenditure by tech giants. However, by 2026, the narrative began to shift. The technology sector experienced significant volatility, and the previously unstoppable rally hit a wall of concern. The central question for investors evolved from "Is AI the future?" to "Has this future already been fully priced in?".

The valuations of many AI-related stocks had become highly extended, leading to what some analysts call "multiple compression," where stock prices fall faster than earnings growth. Investors grew wary of the enormous spending required to build AI infrastructure—over $500 billion in capital expenditure anticipated in 2026—and questioned whether the returns would materialize quickly enough to justify the sky-high prices. Additionally, concerns about the potential for AI to disrupt entire business models, particularly in software and IT services, led to a reassessment of growth assumptions. This created a perfect storm for a "mega-rotation" out of Big Tech and into more reasonably priced sectors.

The Case for Banks: Beneficiaries of a New Reality

As investors sought value, one of the primary beneficiaries has been the banking sector. The case for banks is a classic example of fundamentals driving investment decisions. After years of being weighed down by ultra-low interest rates, European banks in particular have undergone a significant transformation. The return to a more normalised interest rate environment has allowed them to earn healthier spreads on their large deposit bases, boosting core earnings.

Furthermore, the sector is executing a powerful playbook for value creation. Banks are aggressively restructuring their cost bases, leveraging technology to improve efficiency, and returning significant capital to shareholders through dividends and share buybacks. The sector's Common Equity Tier 1 (CET1) ratios, a key measure of financial strength, average roughly 16%, well above regulatory minimums, demonstrating robust balance sheets. More recently, many banks are strategically diversifying their income streams by expanding into less rate-sensitive businesses like wealth and asset management. For example, NatWest's £2.7 billion acquisition of Evelyn Partners marks a major move to build a fee-based revenue base through wealth management, reducing its reliance on traditional lending.

This combination of higher profitability, shareholder-friendly behaviour, and attractive valuations makes banks a compelling destination for capital rotating out of tech. They represent a tangible example of value being created from improved operational performance, not just speculative future potential.

Healthcare: Defensive Strength and Untapped Value

Another sector that has been rediscovered is healthcare. After a period of underperformance relative to technology, healthcare stocks now represent a historic valuation opportunity, with multiples sitting near 30-year lows relative to the broader S&P 500. This is despite accelerating innovation and record strategic demand, with over $318 billion in healthcare M&A in 2025 alone.

The sector offers a blend of defensive characteristics and growth potential. Healthcare demand is generally inelastic, providing a degree of stability during economic uncertainty. However, it also boasts exciting growth avenues, particularly in the private markets where capital is now flowing to companies with proven science and a path to profitability—a principle known as Growth at a Reasonable Price (GARP).

Within the public markets, major players like Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) illustrate the sector's diversity. J&J, trading at a forward P/E of around 20.8, offers a diversified model with strong margins and a robust dividend, while Bristol-Myers, at a forward P/E of 8.8, is a more specialized biopharma play recovering from a challenging period. Both stocks highlight the sector's appeal to investors looking for stable cash flows, reasonable valuations, and less exposure to the extreme volatility seen in tech.

The Return of Fundamental Investing

This broad rotation is, at its heart, a victory for fundamental analysis. After years of "growth at any price" philosophy, investors are re-embracing traditional metrics like price-to-earnings ratios, earnings growth, and dividend yields. The shift out of extended AI valuations into banking and healthcare demonstrates that price still matters.

The market is rewarding companies with strong balance sheets, durable cash flows, and demonstrable earnings power. This is not about abandoning growth entirely. As one analysis points out, even amid the volatility, the earnings outlook for the technology sector remains strong. However, the sheer scale of the valuation premium on tech stocks created a bubble that was ripe for a correction. The rotation is simply the market's way of re-establishing equilibrium, ensuring that a broader range of companies can participate in the rally and that bull markets become "stronger, deeper, and more durable".

In conclusion, the current rotation is a sign of a maturing market. It is a testament to the enduring power of investing in companies with solid fundamentals at reasonable prices. The AI story is far from over, but its dominance is being challenged by other sectors that have quietly built strong economic cases. This broadening of market leadership is a healthy development, proving that even in an era of technological disruption, the old rules of valuation still apply.